AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18589022 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental feeding practices (restriction, pressure to eat, monitoring)
Number of subjects: 239
Study 18589022 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental feeding practices (responsibility, restriction, monitoring, modeling)
Number of subjects: 239
Study 18589022 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental feeding practices (modeling, restriction)
Number of subjects: 239
Study 16171591 — intervention group
Group type: EXPERIMENTAL
Intervention: RCAVF
Number of subjects: 383
Study 16171591 — intervention group
Group type: COMPARATOR
Intervention: Prosthetic AVF
Number of subjects: 383
Study 16171591 — intervention group
Group type: COMPARATOR
Intervention: Prosthetic graft
Number of subjects: 383
Study 12047460 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium valproate (SV) 1000-2000 mg/day
Number of subjects: 96
Study 12047460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 10080417 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow oscillating inflation
Number of subjects: 622
Study 10080417 — intervention group
Group type: COMPARATOR
Intervention: Fast inflation
Number of subjects: 622
Study 7745334 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subgallate as a haemostatic agent
Number of subjects: 100
Study 7745334 — intervention group
Group type: COMPARATOR
Intervention: Control group (no haemostatic substance)
Number of subjects: 100
Study 2039103 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal thiopental 25 mg/kg
Number of subjects: 29
Study 2039103 — intervention group
Group type: COMPARATOR
Intervention: Drug combination (meperidine 2 mg/kg, promethazine 1 mg/kg, chlorpromazine 1 mg/kg)
Number of subjects: 29
Study 2039103 — intervention group
Group type: COMPARATOR
Intervention: Drug combination
Number of subjects: 29
Study 2039103 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study 6988030 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam elastomer dressing
Number of subjects: 50
Study 6988030 — intervention group
Group type: COMPARATOR
Intervention: Conventional gauze packing
Number of subjects: 50
Study 29698971 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound-edge protector (WEP)
Number of subjects: 102
Study 29698971 — intervention group
Group type: COMPARATOR
Intervention: No wound-edge protector (WEP (-))
Number of subjects: 102
Study 28658177 — intervention group
Group type: EXPERIMENTAL
Intervention: Real MENS
Number of subjects: 38
Study 28658177 — intervention group
Group type: COMPARATOR
Intervention: Sham MENS
Number of subjects: 38
Study 25824248 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal sympathetic denervation with the Symplicity Flex Catheter (Medtronic)
Number of subjects: 71
Study 25824248 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 71
Study 23302898 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive pain medication and intraoperative periarticular injections (Group I)
Number of subjects: 82
Study 23302898 — intervention group
Group type: COMPARATOR
Intervention: Not receiving preemptive medication and injections (Group II)
Number of subjects: 82
Study 22766210 — intervention group
Group type: COMPARATOR
Intervention: Group I: Fentanyl 2 mg/kg + Pentothal 5 mg/kg + Vecuronium 0.1 mg/kg
Number of subjects: 3
Study 22766210 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II: Lidocaine 1.5 mg/kg + Fentanyl 2 mg/kg + Pentothal 5 mg/kg + Vecuronium 0.1 mg/kg
Number of subjects: 3
Study 22766210 — intervention group
Group type: EXPERIMENTAL
Intervention: Group III: Lidocaine 1.5 mg/kg + Pentothal 5 mg/kg + Vecuronium 0.1 mg/kg
Number of subjects: 3
Study 19408291 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective selective I, II, III neck dissection (END)
Number of subjects: 71
Study 19408291 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 71
Study 17264340 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal (IP) chemotherapy
Number of subjects: 415
Study 17264340 — intervention group
Group type: COMPARATOR
Intervention: Intravenous (IV) chemotherapy
Number of subjects: 415
Study 15333479 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 IU vitamin E per day for 3 months, increased to 1,200 IU per day for a further 3 months
Number of subjects: 80
Study 15333479 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 80
Study 11465092 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent IL-2 therapy
Number of subjects: 11
Study 9486289 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (1 mg)
Number of subjects: 17
Study 9486289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 8033433 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (IVIG)
Number of subjects: 0
Study 8033433 — intervention group
Group type: COMPARATOR
Intervention: Human albumin 5% (placebo)
Number of subjects: 0
Study 2347035 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (two intradermal injections on days 0, 3, and 7)
Number of subjects: 44
Study 2347035 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (one intradermal and one subcutaneous injection on days 0, 3, and 7)
Number of subjects: 44
Study 2347035 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (two subcutaneous injections on days 0, 3, and 7)
Number of subjects: 44
Study 465440 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g guar gum in bread
Number of subjects: 5
Study 465440 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g guar gum in soup
Number of subjects: 5
Study 465440 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g guar gum (5 g in bread and 5 g in soup)
Number of subjects: 5
Study 31901395 — intervention group
Group type: EXPERIMENTAL
Intervention: Bair Hugger (BH)
Number of subjects: 90
Study 31901395 — intervention group
Group type: COMPARATOR
Intervention: Inditherm (IT)
Number of subjects: 90
Study 30632290 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 μg subcutaneous daily for 12 months
Number of subjects: 20
Study 30632290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 28950268 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ HDM SLIT-tablet
Number of subjects: 1826
Study 28950268 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1826
Study 25451179 — intervention group
Group type: EXPERIMENTAL
Intervention: QUEST A (latissimus dorsi breast reconstruction with postmastectomy radiotherapy unlikely)
Number of subjects: 124
Study 25451179 — intervention group
Group type: EXPERIMENTAL
Intervention: QUEST B (latissimus dorsi breast reconstruction with postmastectomy radiotherapy highly probable)
Number of subjects: 124
Study 25451179 — intervention group
Group type: EXPERIMENTAL
Intervention: QUEST Perspectives Study (QPS)
Number of subjects: 124
Study 23876359 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental external nasal dilator strips (ENDS)
Number of subjects: 48
Study 23876359 — intervention group
Group type: COMPARATOR
Intervention: Placebo external nasal dilator strips
Number of subjects: 48
Study 21880029 — intervention group
Group type: EXPERIMENTAL
Intervention: 20mg rociverine
Number of subjects: 111
Study 21880029 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 111
Study 19588122 — intervention group
Group type: EXPERIMENTAL
Intervention: High or very low tryptophan/LNAA ratios
Number of subjects: 97
Study 19588122 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine/LNAA ratios
Number of subjects: 97
Study 19588122 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylalanine levels
Number of subjects: 97
Study 17874921 — intervention group
Group type: EXPERIMENTAL
Intervention: Multisystemic therapy with high treatment fidelity
Number of subjects: 40
Study 17874921 — intervention group
Group type: COMPARATOR
Intervention: Multisystemic therapy with low treatment fidelity
Number of subjects: 40
Study 15337691 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy (n=153)
Number of subjects: 276
Study 15337691 — intervention group
Group type: COMPARATOR
Intervention: Optimized medical strategy (n=148)
Number of subjects: 276
Study 15337691 — intervention group
Group type: EXPERIMENTAL
Intervention: Both invasive and medical strategies
Number of subjects: 276
Study 15337691 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 276
Study 15337691 — intervention group
Group type: COMPARATOR
Intervention: Optimized medical strategy
Number of subjects: 276
Study 15337691 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization within the first year
Number of subjects: 276
Study 11535214 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC)
Number of subjects: 79
Study 9758290 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg trovafloxacin once daily
Number of subjects: 412
Study 9758290 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg trovafloxacin once daily
Number of subjects: 412
Study 9758290 — intervention group
Group type: COMPARATOR
Intervention: 500 mg amoxicillin three times daily
Number of subjects: 412
Study 9758290 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg trovafloxacin
Number of subjects: 412
Study 9758290 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg trovafloxacin
Number of subjects: 412
Study 9758290 — intervention group
Group type: COMPARATOR
Intervention: 500 mg amoxicillin
Number of subjects: 412
Study 8152575 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg/day (IV before chemotherapy and orally for 4 days)
Number of subjects: 40
Study 8152575 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron 8 mg x 3/day (first dose IV before chemotherapy and subsequent doses orally until the end of the fourth day after chemotherapy)
Number of subjects: 40
Study 3072830 — intervention group
Group type: EXPERIMENTAL
Intervention: S-carboxymethylcysteine (S-CMC) syrup
Number of subjects: 250
Study 3072830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 31526225 — intervention group
Group type: EXPERIMENTAL
Intervention: IIV4
Number of subjects: 346
Study 31526225 — intervention group
Group type: COMPARATOR
Intervention: IIV3
Number of subjects: 346
Study 31526225 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IIV4 and IIV3
Number of subjects: 346
Study 31209699 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal Dilators (VD) used for 3 months
Number of subjects: 88
Study 31209699 — intervention group
Group type: COMPARATOR
Intervention: Standard guidance from the health team (Control Group)
Number of subjects: 88
Study 28801400 — intervention group
Group type: EXPERIMENTAL
Intervention: Guanabenz
Number of subjects: 0
Study 28801400 — intervention group
Group type: COMPARATOR
Intervention: Riluzole
Number of subjects: 0
Study 28801400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26059253 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional intervention including engineering, organizational, and behavioral elements
Number of subjects: 282
Study 26059253 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 282
Study 26059253 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional intervention
Number of subjects: 282
Study 23181712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingesting all medications upon awakening
Number of subjects: 2156
Study 23181712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingesting ≥1 medications at bedtime
Number of subjects: 2156
Study 23181712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingesting all medications at bedtime
Number of subjects: 2156
Study 23181712 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime treatment with ARBs
Number of subjects: 2156
Study 23181712 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime treatment with calcium channel blockers
Number of subjects: 2156
Study 23181712 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingesting ≥1 medications at bedtime (specifically ARBs)
Number of subjects: 2156
Study 21698340 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed-dependent treadmill training
Number of subjects: 26
Study 21698340 — intervention group
Group type: COMPARATOR
Intervention: Steady speed treadmill training (Control)
Number of subjects: 26
Study 19932838 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg/kg (group D)
Number of subjects: 120
Study 19932838 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 10 mg and midazolam 0.075 mg/kg (group DM)
Number of subjects: 120
Study 19932838 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (group C)
Number of subjects: 120
Study 16687084 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study 16687084 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 15110930 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenital adrenal hyperplasia (CAH)
Number of subjects: 128
Study 15110930 — intervention group
Group type: COMPARATOR
Intervention: Unaffected relatives
Number of subjects: 128
Study 15110930 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal androgens
Number of subjects: 128
Study 15110930 — intervention group
Group type: EXPERIMENTAL
Intervention: Handedness
Number of subjects: 128
Study 11142926 — intervention group
Group type: EXPERIMENTAL
Intervention: Willow bark extract (240 mg salicin/day)
Number of subjects: 78
Study 11142926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 11142926 — intervention group
Group type: EXPERIMENTAL
Intervention: Willow bark extract
Number of subjects: 78
Study 9350955 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (407 mg mean daily dose)
Number of subjects: 201
Study 9350955 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine (384 mg mean daily dose)
Number of subjects: 201
Study 8405016 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of pantoprazole (40 mg)
Number of subjects: 12
Study 8405016 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of pantoprazole (40 mg)
Number of subjects: 12
Study 3535986 — intervention group
Group type: EXPERIMENTAL
Intervention: Large dose of caffeine (15 mg X kg‐1)
Number of subjects: 12
Study 3535986 — intervention group
Group type: EXPERIMENTAL
Intervention: Small dose of caffeine (10 mg X kg‐1)
Number of subjects: 12
Study 3535986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3535986 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study 30178066 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaccid unilateral facial paralysis
Number of subjects: 298
Study 30178066 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral moderate to severe postparalytic facial nerve syndrome
Number of subjects: 298
Study 30178066 — intervention group
Group type: COMPARATOR
Intervention: Monocular blindness
Number of subjects: 298
Study 30178066 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-facial reanimation
Number of subjects: 298
Study 28230029 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine 1000 mg/m2 + nedaplatin 20 mg/m2, administered on day 1 and 8 with 21 days per cycle for 3 cycles
Number of subjects: 63
Study 28230029 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil 500 mg/m2 + cisplatin 20 mg/m2, administered on day 1-5 with 21 days per cycle for 3 cycles
Number of subjects: 63
Study 28230029 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study 24760484 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM)
Number of subjects: 489
Study 24760484 — intervention group
Group type: COMPARATOR
Intervention: Western medicine (WM)
Number of subjects: 489
Study 22357022 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) based stress resilience training
Number of subjects: 0
Study 22357022 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological monitoring during VR training
Number of subjects: 0
Study 20532476 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 50
Study 20532476 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone
Number of subjects: 50
Study 20532476 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 50
Study 20532476 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (RECORD trial)
Number of subjects: 50
Study 20532476 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone (RECORD trial)
Number of subjects: 50
Study 20532476 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfonylurea (RECORD trial)
Number of subjects: 50
Study 18176213 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine preoperative showers (liquid detergent-based povidone-iodine 10% 2 hours before surgery)
Number of subjects: 114
Study 18176213 — intervention group
Group type: COMPARATOR
Intervention: Control group (no special instructions for showering before surgery)
Number of subjects: 114
Study 15877299 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg/d
Number of subjects: 21
Study 15877299 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg/d
Number of subjects: 21
Study 15877299 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate 250 mg/d
Number of subjects: 21
Study 12746736 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (10 mg)
Number of subjects: 0
Study 12746736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12746736 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 0
Study 10225074 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen in nitrous oxide 1:2
Number of subjects: 42
Study 10225074 — intervention group
Group type: COMPARATOR
Intervention: Oxygen in air
Number of subjects: 42
Study 8723576 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa 300 IU/kg intravenous (i.v.) twice weekly for 3 weeks
Number of subjects: 0
Study 8723576 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa 100 IU/kg subcutaneous (s.c.) twice weekly for 3 weeks (with a single i.v. bolus of 200 IU/kg at the first s.c. dose)
Number of subjects: 0
Study 8723576 — intervention group
Group type: COMPARATOR
Intervention: Both treatment groups (i.v. and s.c. epoetin alfa)
Number of subjects: 0
Study 8723576 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa (both routes)
Number of subjects: 0
Study 1914619 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine, 120 mg
Number of subjects: 9
Study 1914619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 6362676 — intervention group
Group type: EXPERIMENTAL
Intervention: Kelfiprim (trimethoprim 250 mg + sulfalene 200 mg)
Number of subjects: 46
Study 6362676 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole (trimethoprim 320 mg + sulfamethoxazole 1600 mg)
Number of subjects: 46
Study 6362676 — intervention group
Group type: EXPERIMENTAL
Intervention: Kelfiprim
Number of subjects: 46
Study 6362676 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole
Number of subjects: 46
Study 30621653 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab treatment
Number of subjects: 202
Study 29210520 — intervention group
Group type: EXPERIMENTAL
Intervention: MMN (18 vitamins and minerals including 250 μg iodine per day)
Number of subjects: 1320
Study 29210520 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS (20 g/day of small-quantity lipid-based nutrient supplements with 250 μg iodine)
Number of subjects: 1320
Study 29210520 — intervention group
Group type: COMPARATOR
Intervention: IFA (60 mg iron and 400 μg folic acid per day)
Number of subjects: 1320
Study 26815360 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol + caffeine
Number of subjects: 0
Study 26815360 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol + placebo caffeine
Number of subjects: 0
Study 26815360 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo alcohol + caffeine
Number of subjects: 0
Study 26815360 — intervention group
Group type: COMPARATOR
Intervention: Placebo alcohol + placebo caffeine
Number of subjects: 0
Study 24059254 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial working memory training
Number of subjects: 80
Study 24059254 — intervention group
Group type: COMPARATOR
Intervention: Active control (alternative activities)
Number of subjects: 80
Study 24059254 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial working memory training (young-old)
Number of subjects: 80
Study 21790793 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisturizer containing 0.025% licochalcone
Number of subjects: 72
Study 21790793 — intervention group
Group type: COMPARATOR
Intervention: 1% hydrocortisone
Number of subjects: 72
Study 19353398 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 20599
Study 19353398 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 20599
Study 19353398 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 20599
Study 19353398 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of coronary disease
Number of subjects: 20599
Study 19353398 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin use
Number of subjects: 20599
Study 18186579 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude rhubarb treatment (3 g, tid, p.o)
Number of subjects: 40
Study 18186579 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 18186579 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude rhubarb treatment
Number of subjects: 40
Study 15073700 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminocaproic acid (100 mg/kg after anesthetic induction, 100 mg/kg on CPB, and 100 mg/kg after protamine)
Number of subjects: 150
Study 15073700 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 mg/kg after anesthetic induction, 10 mg/kg on CPB, and 10 mg/kg after protamine)
Number of subjects: 150
Study 15073700 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 11752035 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis to dry weight
Number of subjects: 19